Witryna10 kwi 2024 · ImmunoGen (IMGN) Investor Presentation - Slideshow Nov 20. Analysts increase revenue estimates to US$79.5m Nov 13. Third quarter 2024 earnings released: US$0.13 loss per share Nov 08. Revenue beats expectations, earnings disappoint Nov 08. ImmunoGen EPS beats by $0.06, beats on revenue Witryna1 mar 2024 · The Investor Relations website contains information about ImmunoGen, Inc.'s business for stockholders, potential investors, and financial analysts. WALTHAM, Mass. --(BUSINESS WIRE)--Feb. 1, 2024-- ImmunoGen, Inc. …
Roche Roche’s virtual event at the 2024 ASCO Annual Meeting …
Witryna21 godz. temu · ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, April 28, 2024 to discuss its first quarter 2024 operating results. ... INVESTOR RELATIONS ImmunoGen … WitrynaImmunoGen (NASDAQ:IMGN) investors are sitting on a loss of 66% if they invested five years ago Statistically speaking, long term investing is a profitable endeavour. But … how big are mp3 files
ImmunoGen, Inc. Common Stock (IMGN) - Nasdaq
Witryna2 mar 2024 · ImmunoGen Inc (NASDAQ:IMGN) Q4 2024 Earnings Call dated Mar. 01, 2024. Corporate Participants: Anabel Chan -- Head of Investor Relations Mark … Witryna11 kwi 2024 · About IMGN. ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant … WitrynaGet the latest ImmunoGen, Inc. (IMGN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … how big are mustard seeds